NS Pharma, Inc.
Victoria Ramirez, MPA is a Clinical Research Manager at NS Pharma, Inc. with experience in managing and reporting clinical studies in rare diseases such as Duchenne Muscular Dystrophy. Prior to this role, Victoria worked as a Clinical Trial Associate for Eliassen Group, where Victoria supported COVID-19 trials for Moderna, Inc. Victoria has also held positions as a Clinical Research Associate at ICON plc and Progenity, Inc., focusing on COVID-19 vaccine and maternal health trials. Victoria has a Master of Public Administration in Health Care Administration from Rutgers University and a Bachelor of Arts in Public Administration.
This person is not in any offices
NS Pharma, Inc.
2 followers
NS Pharma, Inc. (NSP) located in Paramus New Jersey is a subsidiary of Nippon Shinyaku Co., Ltd. Founded in 1999 in the United States, NSP is engaged in clinical studies and partnering with global pharmaceutical companies, venture companies and research institutes. NSP serves as a contact point for connecting Japan/Asia and the world, developing drug candidates invented in Japan and out-license them to the world. From the world to Japan/Asia, NSP in-license promising drug candidates to the Japanese/Asian Markets. In coordination with parent company, Nippon Shinyaku, Co., Ltd., NSP will first and foremost develop and supply safe and highly effective pharmaceuticals through clinical studies. NSP aims to be an indispensable entity in the healthcare industry in line with the guidelines for action “Challenge”, “Speed”, and “Investigation”.